Tags

Type your tag names separated by a space and hit enter

Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
Expert Rev Vaccines. 2022 Feb; 21(2):261-267.ER

Abstract

PURPOSE

This population-based study aimed to determine the willingness to receive a booster dose of vaccine against coronavirus disease (COVID-19) in Taizhou, China.

METHODS

An online questionnaire investigation addressing participants' willingness to receive a booster dose of the COVID-19 vaccine was organized in Taizhou, China. Of the 2318 interviewees who received the invitation, 1576 finished a qualifying questionnaire, corresponding to a response rate of 68.0%.

RESULTS

The majority of respondents (n = 1435 [91.1%]) were willing to accept a booster vaccination against COVID-19. History of allergic reaction to other vaccines (OR = 0.30), confidence in the safety of the COVID-19 vaccines (OR = 3.20), confidence in the effectiveness of the COVID-19 vaccines against SARS-CoV-2 (OR = 2.25) and its variants (useful versus [vs.] useless, OR = 2.33), and vaccine recipients (OR = 3.09) remained significantly associated with willingness to accept a booster dose of COVID-19 vaccines.

CONCLUSION

A moderate proportion of the participants who responded were willing to receive a booster dose of the COVID-19 vaccine. These results are valuable for starting health education and interventions to accelerate vaccine uptake and improve public health outcomes during the COVID-19 pandemic in China.

Authors+Show Affiliations

Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34894991

Citation

Tung, Tao-Hsin, et al. "Willingness to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine in Taizhou, China." Expert Review of Vaccines, vol. 21, no. 2, 2022, pp. 261-267.
Tung TH, Lin XQ, Chen Y, et al. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev Vaccines. 2022;21(2):261-267.
Tung, T. H., Lin, X. Q., Chen, Y., Zhang, M. X., & Zhu, J. S. (2022). Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Review of Vaccines, 21(2), 261-267. https://doi.org/10.1080/14760584.2022.2016401
Tung TH, et al. Willingness to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine in Taizhou, China. Expert Rev Vaccines. 2022;21(2):261-267. PubMed PMID: 34894991.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. AU - Tung,Tao-Hsin, AU - Lin,Xiao-Qing, AU - Chen,Yan, AU - Zhang,Mei-Xian, AU - Zhu,Jian-Sheng, Y1 - 2021/12/22/ PY - 2021/12/14/pubmed PY - 2022/2/24/medline PY - 2021/12/13/entrez KW - COVID-19 KW - China KW - booster dose KW - willingness SP - 261 EP - 267 JF - Expert review of vaccines JO - Expert Rev Vaccines VL - 21 IS - 2 N2 - PURPOSE: This population-based study aimed to determine the willingness to receive a booster dose of vaccine against coronavirus disease (COVID-19) in Taizhou, China. METHODS: An online questionnaire investigation addressing participants' willingness to receive a booster dose of the COVID-19 vaccine was organized in Taizhou, China. Of the 2318 interviewees who received the invitation, 1576 finished a qualifying questionnaire, corresponding to a response rate of 68.0%. RESULTS: The majority of respondents (n = 1435 [91.1%]) were willing to accept a booster vaccination against COVID-19. History of allergic reaction to other vaccines (OR = 0.30), confidence in the safety of the COVID-19 vaccines (OR = 3.20), confidence in the effectiveness of the COVID-19 vaccines against SARS-CoV-2 (OR = 2.25) and its variants (useful versus [vs.] useless, OR = 2.33), and vaccine recipients (OR = 3.09) remained significantly associated with willingness to accept a booster dose of COVID-19 vaccines. CONCLUSION: A moderate proportion of the participants who responded were willing to receive a booster dose of the COVID-19 vaccine. These results are valuable for starting health education and interventions to accelerate vaccine uptake and improve public health outcomes during the COVID-19 pandemic in China. SN - 1744-8395 UR - https://www.unboundmedicine.com/medline/citation/34894991/Willingness_to_receive_a_booster_dose_of_inactivated_coronavirus_disease_2019_vaccine_in_Taizhou_China_ DB - PRIME DP - Unbound Medicine ER -